Literature DB >> 9765171

The muscular dystrophies.

A E Emery1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9765171      PMCID： PMC1114045          DOI： 10.1136/bmj.317.7164.991

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  50th ENMC International Workshop: congenital muscular dystrophy. 28 February 1997 to 2 March 1997, Naarden, The Netherlands.

Authors:  V Dubowitz
Journal:  Neuromuscul Disord       Date:  1997-12       Impact factor: 4.296

Review 2.  MUSCULAR DYSTROPHY: SOME RECENT ADVANCES IN KNOWLEDGE.

Authors:  J N WALTON
Journal:  Br Med J       Date:  1964-05-16

Review 3.  MUSCULAR DYSTROPHY: SOME RECENT ADVANCES IN KNOWLEDGE.

Authors:  J N WALTON
Journal:  Br Med J       Date:  1964-05-23

Review 4.  Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy.

Authors:  J S Beckmann; K M Bushby
Journal:  Curr Opin Neurol       Date:  1996-10       Impact factor: 5.710

5.  47th ENMC International Workshop: Treatment of Muscular Dystrophy. 13-15 December 1996, Naarden, The Netherlands.

Authors: 
Journal:  Neuromuscul Disord       Date:  1997-06       Impact factor: 4.296

6.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

7.  Development and validation of laboratory procedures for preimplantation diagnosis of Duchenne muscular dystrophy.

Authors:  C Holding; D Bentley; R Roberts; M Bobrow; C Mathew
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

8.  Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.

Authors:  A E Deconinck; J A Rafael; J A Skinner; S C Brown; A C Potter; L Metzinger; D J Watt; J G Dickson; J M Tinsley; K E Davies
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Autosomal dominant distal myopathy: linkage to chromosome 14.

Authors:  N G Laing; B A Laing; C Meredith; S D Wilton; P Robbins; K Honeyman; S Dorosz; H Kozman; F L Mastaglia; B A Kakulas
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Congenital muscular dystrophy with merosin deficiency.

Authors:  F M Tomé; T Evangelista; A Leclerc; Y Sunada; E Manole; B Estournet; A Barois; K P Campbell; M Fardeau
Journal:  C R Acad Sci III       Date:  1994-04
View more
  37 in total

Review 1.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

2.  A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families.

Authors:  P Dinçer; Z Akçören; E Demir; I Richard; O Sancak; G Kale; S Ozme; A Karaduman; E Tan; J A Urtizberea; J S Beckmann; H Topaloğlu
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

3.  Quantifying myofiber integrity using diffusion MRI and random permeable barrier modeling in skeletal muscle growth and Duchenne muscular dystrophy model in mice.

Authors:  Kerryanne V Winters; Olivier Reynaud; Dmitry S Novikov; Els Fieremans; Sungheon Gene Kim
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

4.  Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures.

Authors:  M P Lewis; H L Tippett; A C Sinanan; M J Morgan; N P Hunt
Journal:  J Muscle Res Cell Motil       Date:  2000-04       Impact factor: 2.698

5.  Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo.

Authors:  Michelle L Law; Kurt W Prins; Megan E Olander; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

6.  Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.

Authors:  ThuyQuynh N Do; Natalie Street; Jennifer Donnelly; Melissa M Adams; Christopher Cunniff; Deborah J Fox; Richard O Weinert; Joyce Oleszek; Paul A Romitti; Christina P Westfield; Julie Bolen
Journal:  Birth Defects Res       Date:  2018-08-02       Impact factor: 2.344

7.  Computer-aided visualization of muscle weakness distribution.

Authors:  Allan J Pieterse; Nicol C Voermans; Hans S Tuinenga; Baziel G M van Engelen
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

8.  Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy.

Authors:  Andrea Farini; Clementina Sitzia; Barbara Cassani; Letizia Cassinelli; Rosita Rigoni; Federica Colleoni; Nicola Fusco; Stefano Gatti; Pamela Bella; Chiara Villa; Filomena Napolitano; Rita Maiavacca; Silvano Bosari; Anna Villa; Yvan Torrente
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

Review 9.  Wnt signaling in bone and muscle.

Authors:  Michael A Rudnicki; Bart O Williams
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

10.  Atypical manifestation of late onset limb girdle muscular dystrophy presenting with recurrent falling and shoulder dysfunction: a case report.

Authors:  Markus Dietmar Schofer; Thilo Patzer; Markus Quante
Journal:  Cases J       Date:  2008-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.